An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein
- PMID: 25393017
- PMCID: PMC4231124
- DOI: 10.1371/journal.pone.0113144
An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein
Abstract
Advanced glycation end products (AGEs) are thought to contribute to the abnormal lipoprotein profiles and increased risk of cardiovascular disease in patients with diabetes and renal failure. D-ribose is one of the naturally occurring pentose monosaccharide present in all living cells and is a key component of numerous biomolecules involved in many important metabolic pathways. Formation of D-ribose derived glycated low density lipoprotein (LDL) has been previously demonstrated but no studies have been performed to assess the immune complex deposition in the kidney of rabbits immunized with glycated LDL. In this study, LDL was glycated with D-ribose, and it was further used as an immunogen for immunizing NZW female rabbits. The results showed that female rabbits immunized with D-ribose modified LDL induced antibodies as detected by direct binding and competitive ELISA. The modified LDL was found to be highly immunogenic eliciting high titer immunogen-specific antibodies, while the native forms were moderately immunogenic. The induced antibodies from modified LDL exhibited wide range of heterogeneity in recognizing various proteins and amino acids conformers. Furthermore, our histopathological results illustrated the deposits of immune complex in glomerular basement membrane in rabbits immunized with D-ribose-LDL.
Conflict of interest statement
Figures




References
-
- Gillery P, Jenison S (2014) Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med 52(1): 33–38. - PubMed
-
- Lapolla A, Traldi P, Fedele D (2005) Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38: 103–115. - PubMed
-
- Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation 114: 597–605. - PubMed
-
- Azevedo M, Falcao J, Raposo J, Manso C (1988) Free Radic Res Commun. 4: 331–335. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources